Metoclopramide

Author Dr. Riya Patel
Updated on 7/18/2020 10:37:37 PM

1.What is Metoclopramide?

Metoclopramide is a medication commonly used in veterinary medicine to treat nausea, vomiting, and gastrointestinal motility disorders in animals such as dogs and cats. It is a prokinetic agent, meaning it helps increase the motility of the stomach and intestines, facilitating the movement of stomach contents through the gastrointestinal tract. Additionally, metoclopramide acts as an antiemetic by blocking dopamine receptors in the chemoreceptor trigger zone of the brain, which helps control nausea and vomiting.

2.How does Metoclopramide work?

Metoclopramide is a medication that plays a vital role in veterinary medicine due to its dual action as both a prokinetic agent and an antiemetic. Here's how metoclopramide works in animals:

Prokinetic Action:

Stimulation of Gastrointestinal Motility: Metoclopramide primarily acts by stimulating the upper gastrointestinal tract, which is beneficial for animals with delayed gastric emptying. It increases the tone and amplitude of gastric (especially antral) contractions. Also, it relaxes the pyloric sphincter and duodenal bulb, while increasing the peristaltic activity of the duodenum and jejunum. These actions facilitate the rapid movement of stomach contents into the intestines.

Mechanism: This prokinetic effect is mainly achieved through the drug's antagonistic action on dopamine receptors, which are known to inhibit gastrointestinal motility. Additionally, metoclopramide stimulates motility by enhancing the release of acetylcholine, a neurotransmitter that promotes muscle contraction in the gut.

Antiemetic Action:

Control of Vomiting: Metoclopramide is effective in controlling vomiting, which can be a critical issue in veterinary care. It works as an antiemetic primarily by blocking dopamine receptors in the chemoreceptor trigger zone (CTZ) of the central nervous system. This zone, located outside the blood-brain barrier, is responsible for inducing vomiting when stimulated by toxins, drugs, or certain disease processes.

Additional Serotonergic Effects: Metoclopramide also has some effects on serotonin receptors, which may contribute to its antiemetic properties, though this action is less prominent than its effects on dopamine receptors.

Understanding the dual action of metoclopramide on both gastrointestinal motility and vomiting centers provides a basis for its use in managing a variety of gastrointestinal conditions in veterinary practice. Always consult with a veterinarian to ensure its appropriate use tailored to the specific medical needs and condition of the animal.

3.What are the indications for Metoclopramide?

Metoclopramide is a versatile medication in veterinary medicine, used primarily for its antiemetic and prokinetic effects. Here’s a detailed look at the indications for using metoclopramide in animals:

Gastrointestinal Motility Disorders:

Gastroparesis: Metoclopramide is effective in treating gastroparesis, a condition where the stomach empties too slowly, which can cause bloating, nausea, and vomiting.

Gastroesophageal Reflux Disease (GERD): By enhancing gastric emptying and increasing lower esophageal sphincter tone, metoclopramide helps manage reflux and prevents the backflow of stomach acid into the esophagus, which can be particularly harmful in sedated or anesthetized animals.

Prevention and Control of Vomiting:

Pre- and Post-operative Care: Metoclopramide is commonly used to prevent nausea and vomiting associated with surgery, especially when opiates are used for anesthesia, as it helps in emptying the stomach contents.

Chemotherapy-induced Nausea: In veterinary oncology, metoclopramide helps manage nausea and vomiting caused by certain chemotherapeutic agents.

Toxin Ingestion: It is also used to control vomiting in cases of toxin ingestion, which can help prevent further absorption of the toxin from the stomach.

Aid in Diagnostic Procedures:

Radiographic Examinations: Metoclopramide can be used to facilitate certain diagnostic procedures that require an empty stomach, such as imaging studies, by accelerating gastric emptying.

Adjunct Treatment for Small Intestinal Hypomotility:

Enhancing Intestinal Motility: It is sometimes used to stimulate motility in the small intestine, aiding the management of conditions where reduced motility is a problem, thereby preventing ileus and similar conditions.

Aspiration Pneumonia Prevention:

Risk Reduction in Prone Animals: In animals with conditions that predispose them to aspiration pneumonia, such as those with severe neurological deficits affecting swallowing, metoclopramide can help reduce the risk by promoting gastric emptying.

Metoclopramide is a useful medication for managing various conditions related to gastrointestinal dysfunction and is particularly valued for its ability to both enhance gastrointestinal motility and control vomiting. However, like all medications, it should be prescribed and administered under the guidance of a veterinarian to ensure it is used safely and effectively.

4.What is the dosage and Administration for Metoclopramide?

Metoclopramide is used in veterinary medicine to treat nausea, stimulate gastric motility, and manage vomiting in animals, particularly dogs and cats. The dosage and administration can vary depending on the animal's weight, the specific condition being treated, and individual response. Here are general guidelines for the dosage and administration of metoclopramide for dogs and cats:

Dosage for Dogs:

Standard Dosing: The typical dosage for dogs is 0.1 to 0.5 mg per kilogram of body weight.

Frequency: This dosage is administered every 6 to 8 hours, depending on the severity of the condition and the response to treatment.

Administration Methods: Metoclopramide can be administered orally, subcutaneously, or intravenously, depending on the clinical situation. Oral administration is common for ongoing management, while injectable forms are used for more acute conditions.

Dosage for Cats:

Standard Dosing: For cats, the dosage typically ranges from 0.1 to 0.5 mg per kilogram of body weight.

Frequency: Similar to dogs, this dosage is given every 6 to 8 hours.

Administration Methods: Cats can receive metoclopramide orally or intravenously. Injectable forms are particularly used in hospital settings for acute management.

Key Considerations:

Duration of Treatment: The duration of metoclopramide administration depends on the underlying cause of the symptoms and the animal's response to the medication. It may be used for short periods around surgery or for longer durations in chronic conditions.

Monitoring: Close monitoring is essential to adjust the dosage as needed and to observe for side effects, especially if the animal is receiving metoclopramide long-term.

Administration Tips:

Injectable Form: When given intravenously, it should be administered slowly to minimize the risk of side effects.

Oral Form: Oral tablets or liquid formulations are suitable for home use, and it's important to administer them at regular intervals to maintain an effective concentration of the drug in the bloodstream.

Metoclopramide's effectiveness and safety in treating gastrointestinal and vomiting issues make it a valuable tool in veterinary medicine. However, it should always be used under the guidance of a veterinarian who can provide specific recommendations based on the individual animal's health condition.

5.What are the side effects of Metoclopramide?

Metoclopramide is a medication used in veterinary medicine to manage gastrointestinal disorders and prevent nausea and vomiting in animals such as dogs and cats. While it is generally safe and effective when used according to a veterinarian's prescription, metoclopramide can cause some side effects. Being aware of these potential adverse effects is important for monitoring and managing the health of animals under treatment. Here are the common and less common side effects associated with metoclopramide in animals:

Common Side Effects:

Behavioral Changes: Animals may exhibit restlessness or changes in behavior. This is due to the drug's action on dopamine receptors in the brain.

Gastrointestinal Upset: Despite its use to treat nausea, metoclopramide can sometimes cause gastrointestinal issues such as diarrhea or, less commonly, constipation.

Sedation: Some animals may experience sedation, although this is generally mild.

Less Common but Serious Side Effects:

Extrapyramidal Symptoms: These neurological effects, including muscle spasms, altered movement, and tremors, can occur due to the drug's action on the central nervous system. These are rare but can be serious if they occur.

Hyperactivity: Some animals may show signs of hyperactivity as an adverse reaction to the drug.

Endocrine Changes: Metoclopramide can influence prolactin levels due to its dopaminergic effects, potentially affecting hormonal balances.

Rare Side Effects:

Hypotension: Especially when administered intravenously, metoclopramide can lead to low blood pressure.

Tachycardia: An increase in heart rate can occur, particularly following IV administration.

In conclusion, while metoclopramide is a useful drug for managing gastrointestinal disorders and preventing vomiting in veterinary patients, it can cause a range of side effects. Responsible management under veterinary guidance and careful monitoring are crucial to safely benefit from its use.

6.What circumstances should Metoclopramide not be used?

Metoclopramide is an effective medication for managing gastrointestinal motility disorders and controlling nausea and vomiting in veterinary medicine. However, there are certain circumstances where its use should be avoided or considered very carefully due to potential risks or exacerbated conditions. Here are the key scenarios in which metoclopramide should not be used or should be used with caution in animals:

Gastrointestinal Obstruction:

Reason for Caution: Metoclopramide stimulates gastric motility, which can be dangerous if there is a physical blockage, such as a gastrointestinal obstruction. Using metoclopramide in such cases can lead to increased pressure, perforation, or severe damage to the gastrointestinal tract.

Gastrointestinal Perforation or Hemorrhage:

Reason for Caution: Similar to its contraindication in cases of obstruction, metoclopramide should not be used if there is any suspicion of gastrointestinal perforation or active hemorrhage, as enhanced motility could exacerbate these conditions.

History of Seizures:

Reason for Caution: Metoclopramide can lower the seizure threshold due to its central nervous system activity. Animals with a history of seizures may experience exacerbated or more frequent seizures under this medication.

Pheochromocytoma:

Reason for Caution: In animals diagnosed with pheochromocytoma, a type of tumor that affects adrenal gland function, metoclopramide should be avoided because it can potentially cause a severe hypertensive crisis.

Concomitant Use with Certain Medications:

Reason for Caution: Metoclopramide can interact with other medications, particularly those that also affect the central nervous system, such as certain sedatives, anxiolytics, and anesthetics. It can also interact with medications that are metabolized by similar pathways in the liver, increasing the risk of drug toxicity.

Sensitivity to Drug:

Reason for Caution: Animals known to be hypersensitive or allergic to metoclopramide should not receive this medication as they are at risk of an allergic reaction, which could be severe.

Understanding these contraindications and handling them with appropriate veterinary oversight ensures that metoclopramide is used safely and effectively, maximizing benefits while minimizing risks to animal patients.

7.What drug interactions should be noted when using Metoclopramide?

Metoclopramide, commonly used in veterinary medicine for its prokinetic and antiemetic properties, can interact with several other medications. Being aware of these interactions is crucial for ensuring the safe and effective use of the drug in animals. Here are some notable drug interactions to consider when administering metoclopramide:

Central Nervous System (CNS) Depressants:

Interaction: Metoclopramide may potentiate the sedative effects of other CNS depressants, such as barbiturates, tranquilizers (e.g., acepromazine), and anesthetics. This can lead to increased sedation or even profound respiratory depression.

Management: Careful monitoring and possible dose adjustment of both metoclopramide and the CNS depressant may be necessary.

Anticholinergic Medications:

Interaction: Anticholinergic drugs (e.g., atropine, some antihistamines) can counteract the prokinetic effects of metoclopramide by inhibiting gastric motility. This could diminish the effectiveness of metoclopramide.

Management: Monitoring the therapeutic response to metoclopramide when used concurrently with anticholinergic medications is recommended.

Dopamine Antagonists:

Interaction: Metoclopramide’s mode of action includes dopamine antagonism, which can be intensified when used with other dopamine antagonists such as phenothiazines or butyrophenones. This could increase the risk of extrapyramidal symptoms (movement disorders).

Management: Watch for neurological signs and consider dosage adjustments as needed.

Digoxin:

Interaction: Metoclopramide may increase the absorption rate of digoxin, potentially leading to higher plasma concentrations.

Management: Monitoring digoxin levels and adjusting the digoxin dose may be necessary.

Diabetic Medications:

Interaction: Metoclopramide can alter the absorption of drugs, which may affect blood glucose levels and the efficacy of diabetic treatments.

Management: Blood glucose levels should be monitored closely, and adjustments to diabetic medication dosages may be required.

Tetracycline:

Interaction: Metoclopramide can increase the absorption of tetracycline, potentially leading to higher plasma concentrations of the antibiotic.

Management: Monitor for signs of antibiotic overdose and adjust the tetracycline dosage as needed.

Monoamine Oxidase Inhibitors (MAOIs):

Interaction: Although less common in veterinary medicine, combining MAOIs with metoclopramide can increase the risk of hypotension and other adverse cardiovascular effects.

Management: Use with caution and monitor cardiovascular function if these drugs must be used together.

Opioids:

Interaction: Metoclopramide can enhance the sedative and constipating effects of opioids, which might be detrimental, especially in animals with gastrointestinal motility issues.

Management: Monitor the animal for increased sedation or decreased gastrointestinal motility, and adjust opioid dosages as necessary.

Monitoring and Veterinary Oversight:

Proper management of drug interactions involves careful consideration of all medications an animal is receiving. Regular veterinary monitoring is essential to adjust dosages and manage any adverse effects effectively. Always consult a veterinarian before combining metoclopramide with other medications to ensure safe and effective treatment for animal patients.

8.Pharmacokinetics of Metoclopramide.

Metoclopramide is a medication commonly used in veterinary medicine due to its prokinetic and antiemetic properties. Understanding its pharmacokinetics—how the drug is absorbed, distributed, metabolized, and excreted—can help veterinarians effectively manage its use in treating animals, especially dogs and cats. Here’s a detailed look at the pharmacokinetics of metoclopramide:

Absorption:

Rapid Absorption: Metoclopramide is well-absorbed after oral administration, with bioavailability generally high in most animals. The onset of action is relatively quick, with effects on gastric motility beginning within 10 to 15 minutes when administered intravenously, and within 30 minutes to 2 hours when given orally, depending on the stomach's content.

Distribution:

Wide Distribution: After absorption, metoclopramide is distributed widely throughout the body. It can cross the blood-brain barrier, which is significant for its antiemetic effects as it acts on the chemoreceptor trigger zone (CTZ) in the brain.

Protein Binding: Metoclopramide has a moderate degree of protein binding, reported to be between 30% and 40% in humans and likely similar in animals.

Metabolism:

Liver Metabolism: Metoclopramide is primarily metabolized in the liver. The metabolic pathways involve N-dealkylation and aromatic hydroxylation. The rate and extent of metabolism can vary significantly between species and individual animals, which may affect dosing regimens.

Species Variation: There is evidence suggesting that cats may metabolize metoclopramide slower than dogs, potentially requiring adjustments in dosing frequency or amounts.

Excretion:

Renal Excretion: The primary route of excretion for metoclopramide is through the kidneys. Both the unchanged drug and its metabolites are excreted in the urine. This is particularly important for animals with renal impairment, as they may require dose adjustments to prevent drug accumulation and toxicity.

Half-life: The elimination half-life of metoclopramide varies by species and individual health conditions. In dogs, the half-life is approximately 1.5 to 2.5 hours. In cats, the half-life might be longer, necessitating less frequent dosing to avoid side effects.

Clinical Implications:

Dosing Adjustments: Due to the variability in metabolism and excretion among animals, especially between dogs and cats, dosing regimens should be tailored to the individual animal based on its specific pharmacokinetic response. Regular monitoring and adjustments may be necessary.

Consideration of Health Status: Animals with liver or kidney disease might require lower doses or increased intervals between doses to accommodate their decreased ability to metabolize and excrete the drug.

Understanding these pharmacokinetic parameters allows veterinarians to optimize the use of metoclopramide, ensuring effective treatment while minimizing the risk of side effects. This is crucial for the successful management of gastrointestinal disorders and control of vomiting in veterinary patients.

Commonly Prescribed For

Dosage form

  • Tablet
  • Oral Solution
  • Injectable Solution

Customization of Medicines

Start a partnership


  • Copyright©2024
  • EGN VETERINARY LABORATORY